Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction

Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction

US Patent 8367333 · Granted Feb 5, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Genetic variants for breast cancer risk assessment2015
Genetic variants contributing to risk of prostate cancer2014
Susceptibility variants for lung cancer2014
Susceptibility variants for peripheral arterial disease and abdominal aortic ane2014
Genetic markers for risk management of atrial fibrillation and stroke2014
Genetic markers associated with risk of diabetes mellitus2014
Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer2014
Genetic markers for risk management of atrial fibrillation, atrial flutter, and 2014
Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk 2013